Copyright Reports & Markets. All rights reserved.

Global Platelet Rich Plasma Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Platelet Rich Plasma Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Pure PRP
      • 1.4.3 Leukocyte-Rich PRP
      • 1.4.4 Leukocyte-Rich Fibrin
    • 1.5 Market by Application
      • 1.5.1 Global Platelet Rich Plasma Market Share by Application (2014-2025)
      • 1.5.2 Orthopedics
      • 1.5.3 Cosmetic Surgery & Dermatology
      • 1.5.4 Ophthalmic Surgery
      • 1.5.5 Neurosurgery
      • 1.5.6 General surgery
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Platelet Rich Plasma Market Size
    • 2.2 Platelet Rich Plasma Growth Trends by Regions
      • 2.2.1 Platelet Rich Plasma Market Size by Regions (2014-2025)
      • 2.2.2 Platelet Rich Plasma Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Platelet Rich Plasma Market Size by Manufacturers
      • 3.1.1 Global Platelet Rich Plasma Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Platelet Rich Plasma Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Platelet Rich Plasma Market Concentration Ratio (CR5 and HHI)
    • 3.2 Platelet Rich Plasma Key Players Head office and Area Served
    • 3.3 Key Players Platelet Rich Plasma Product/Solution/Service
    • 3.4 Date of Enter into Platelet Rich Plasma Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Platelet Rich Plasma Market Size by Type (2014-2019)
    • 4.2 Global Platelet Rich Plasma Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Platelet Rich Plasma Market Size (2014-2019)
    • 5.2 Platelet Rich Plasma Key Players in United States
    • 5.3 United States Platelet Rich Plasma Market Size by Type
    • 5.4 United States Platelet Rich Plasma Market Size by Application

    6 Europe

    • 6.1 Europe Platelet Rich Plasma Market Size (2014-2019)
    • 6.2 Platelet Rich Plasma Key Players in Europe
    • 6.3 Europe Platelet Rich Plasma Market Size by Type
    • 6.4 Europe Platelet Rich Plasma Market Size by Application

    7 China

    • 7.1 China Platelet Rich Plasma Market Size (2014-2019)
    • 7.2 Platelet Rich Plasma Key Players in China
    • 7.3 China Platelet Rich Plasma Market Size by Type
    • 7.4 China Platelet Rich Plasma Market Size by Application

    8 Japan

    • 8.1 Japan Platelet Rich Plasma Market Size (2014-2019)
    • 8.2 Platelet Rich Plasma Key Players in Japan
    • 8.3 Japan Platelet Rich Plasma Market Size by Type
    • 8.4 Japan Platelet Rich Plasma Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Platelet Rich Plasma Market Size (2014-2019)
    • 9.2 Platelet Rich Plasma Key Players in Southeast Asia
    • 9.3 Southeast Asia Platelet Rich Plasma Market Size by Type
    • 9.4 Southeast Asia Platelet Rich Plasma Market Size by Application

    10 India

    • 10.1 India Platelet Rich Plasma Market Size (2014-2019)
    • 10.2 Platelet Rich Plasma Key Players in India
    • 10.3 India Platelet Rich Plasma Market Size by Type
    • 10.4 India Platelet Rich Plasma Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Platelet Rich Plasma Market Size (2014-2019)
    • 11.2 Platelet Rich Plasma Key Players in Central & South America
    • 11.3 Central & South America Platelet Rich Plasma Market Size by Type
    • 11.4 Central & South America Platelet Rich Plasma Market Size by Application

    12 International Players Profiles

    • 12.1 AdiStem Ltd.
      • 12.1.1 AdiStem Ltd. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Platelet Rich Plasma Introduction
      • 12.1.4 AdiStem Ltd. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.1.5 AdiStem Ltd. Recent Development
    • 12.2 Arthrex, Inc.
      • 12.2.1 Arthrex, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Platelet Rich Plasma Introduction
      • 12.2.4 Arthrex, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.2.5 Arthrex, Inc. Recent Development
    • 12.3 Biomet, Inc.
      • 12.3.1 Biomet, Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Platelet Rich Plasma Introduction
      • 12.3.4 Biomet, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.3.5 Biomet, Inc. Recent Development
    • 12.4 Cesca Therapeutics, Inc.
      • 12.4.1 Cesca Therapeutics, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Platelet Rich Plasma Introduction
      • 12.4.4 Cesca Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.4.5 Cesca Therapeutics, Inc. Recent Development
    • 12.5 DePuy Synthes, Inc.
      • 12.5.1 DePuy Synthes, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Platelet Rich Plasma Introduction
      • 12.5.4 DePuy Synthes, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.5.5 DePuy Synthes, Inc. Recent Development
    • 12.6 EmCyte Corporation
      • 12.6.1 EmCyte Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Platelet Rich Plasma Introduction
      • 12.6.4 EmCyte Corporation Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.6.5 EmCyte Corporation Recent Development
    • 12.7 Exactech, Inc.
      • 12.7.1 Exactech, Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Platelet Rich Plasma Introduction
      • 12.7.4 Exactech, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.7.5 Exactech, Inc. Recent Development
    • 12.8 Harvest Technologies Corp.
      • 12.8.1 Harvest Technologies Corp. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Platelet Rich Plasma Introduction
      • 12.8.4 Harvest Technologies Corp. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.8.5 Harvest Technologies Corp. Recent Development
    • 12.9 Nuo Therapeutics, Inc.
      • 12.9.1 Nuo Therapeutics, Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Platelet Rich Plasma Introduction
      • 12.9.4 Nuo Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.9.5 Nuo Therapeutics, Inc. Recent Development
    • 12.10 Regen Lab SA
      • 12.10.1 Regen Lab SA Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Platelet Rich Plasma Introduction
      • 12.10.4 Regen Lab SA Revenue in Platelet Rich Plasma Business (2014-2019)
      • 12.10.5 Regen Lab SA Recent Development
    • 12.11 Stryker Corporation

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel.
      In 2018, the global Platelet Rich Plasma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Platelet Rich Plasma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Platelet Rich Plasma development in United States, Europe and China.

      The key players covered in this study
      AdiStem Ltd.
      Arthrex, Inc.
      Biomet, Inc.
      Cesca Therapeutics, Inc.
      DePuy Synthes, Inc.
      EmCyte Corporation
      Exactech, Inc.
      Harvest Technologies Corp.
      Nuo Therapeutics, Inc.
      Regen Lab SA
      Stryker Corporation

      Market segment by Type, the product can be split into
      Pure PRP
      Leukocyte-Rich PRP
      Leukocyte-Rich Fibrin

      Market segment by Application, split into
      Orthopedics
      Cosmetic Surgery & Dermatology
      Ophthalmic Surgery
      Neurosurgery
      General surgery
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Platelet Rich Plasma status, future forecast, growth opportunity, key market and key players.
      To present the Platelet Rich Plasma development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Platelet Rich Plasma are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now